What question did this study set out to answer?

The aim is to develop a triple-stage protocol that utilizes the gallbladder to stimulate systemic immune responses in advanced gallbladder cancer.

April 22, 2026Open Access

A Triple-Stage Autologous Immunotherapy Protocol for Advanced Gallbladder Cancer: A Paradigm Shift from Physical Resection to Physiological Synergy

Key Points

The aim is to develop a triple-stage protocol that utilizes the gallbladder to stimulate systemic immune responses in advanced gallbladder cancer.
Developed LPBE-GVC protocol in three phases: antigen priming, lymphatic navigation, and hyperthermic clearance.
Utilized mechanical fragmentation and hyperthermic baths to convert tumors into autologous antigens.
Administered antigen fragments into lymph nodes to provoke systemic immune activity.
Projected immune-mediated reduction of peritoneal nodules and ascites absorption.
Anticipated decrease in surgery duration from 10 hours to 60 minutes.
Expected improvement in EORTC QLQ-C30 quality of life scores through better metabolic integrity.

Abstract

Background Advanced gallbladder cancer (GBC) with hepatic infiltration and peritoneal seeding presents a clinical impasse. Traditional radical resection offers limited efficacy against micro-metastasis while severely compromising the patient's quality of life (QoL). I propose LPBE-GVC (Gallbladder Vaccine Cradle), a non-resectional triple-stage protocol designed to utilize the gallbladder as an in-situ bioreactor to induce systemic immune self-healing. Methods The protocol comprises three strategic phases: (1) Phase I: In-situ Antigen Priming – Establishing a sequestered environment via cystic duct clipping, followed by mechanical fragmentation and a 42°C normobaric hyperthermic bath to transform the tumor into high-quality autologous antigens. (2) Phase II: Lymphatic Navigation (LPBE Mobilization) – Within 24 hours, diluted NAFs (Antigen Fragments) are administered via Pressure-Balanced Entry (LPBE) into targeted regional lymph nodes to trigger systemic immune scanning. (3) Phase III: Hyperthermic Global Clearance – Continuous abdominal heating at 40°C for seven days to lower Interstitial Fluid Pressure (IFP), facilitating T-cell infiltration into metastatic sites. Expected Outcomes The LPBE-GVC protocol is projected to achieve significant immune-mediated cavitation of peritoneal nodules and absorption of ascites, theoretically demonstrating a "Biochemical Margin" that exceeds traditional physical boundaries. By shifting the surgical objective, we anticipate a reduction in operative time from 10 hours to 60 minutes, with a correlated improvement in EORTC QLQ-C30 scores through the preservation of full metabolic integrity. Interpretation The LPBE-GVC protocol demonstrates that "non-resection" is not merely a humanitarian Boon but a scientifically superior choice. By precisely modulating physical parameters, We enable the conversion of localized lesions into a systemic vaccine. This innovative logic aligns with established immunological principles, offering a transformative path for clinicians to overcome the current dilemmas in HPB oncology. Original publication on SSRN: https://doi.org/10.2139/ssrn.6541707

Read Full Paperexternally

KI fragen

Bookmark

View Full Paper